Literature DB >> 24841367

The evolution of pediatric tele-echocardiography: 15-year experience of over 10,000 transmissions.

Anita Krishnan1, Mary Fuska, Ron Dixon, Craig A Sable.   

Abstract

BACKGROUND: Telemedicine transmission of echocardiograms, either in real-time or using store-and-forward technology, is used to evaluate infants with suspected heart disease. The impact of Internet protocol (IP) technology on telecardiology utilization is unknown. This study evaluated the impact of IP expansion on telecardiology utilization and mode of scanning.
MATERIALS AND METHODS: The telemedicine database from 1998 to 2012 at our institution was reviewed. Tele-echocardiography transmissions between 1998 to 2012 were identified. IP technology was introduced in 2006. The database was reviewed to compare telecardiology utilization and mode of scanning of transmission (live, store-and-forward, or both). As a secondary aim, indications for telemedicine echocardiograms, outcomes of studies, effectiveness, and efficiency were recorded.
RESULTS: Between 1998 and 2012, 11,890 telemedicine transmissions were performed. After IP expansion, telecardiology utilization increased significantly with no adverse effect on efficiency or diagnostic accuracy. IP expansion paralleled a change from live transmissions to store-and-forward transmissions. Abnormalities were detected in over 40% of studies. The average from time of request to completion of teleconsultation was under 30 min. Over 90% of echocardiograms were performed during the videoconference in the first 2 years. This fell to under 60% during the 2 most recent years of the program without impact on accuracy.
CONCLUSIONS: Use of IP technology at a single center corresponded to a dramatic increase in volume of telemedicine echocardiograms, with no significant differences in efficiency.

Entities:  

Keywords:  cardiology/cardiovascular disease; education; telehealth; telemedicine

Mesh:

Year:  2014        PMID: 24841367     DOI: 10.1089/tmj.2013.0279

Source DB:  PubMed          Journal:  Telemed J E Health        ISSN: 1530-5627            Impact factor:   3.536


  7 in total

Review 1.  Addressing health disparities in rural communities using telehealth.

Authors:  James P Marcin; Ulfat Shaikh; Robin H Steinhorn
Journal:  Pediatr Res       Date:  2015-10-14       Impact factor: 3.756

2.  Using remote consultation to enhance diagnostic accuracy of bedside transthoracic echocardiography during COVID-19 pandemic.

Authors:  Jing Lu; Jun Lin; Lixue Yin; Rui Shi; Huanxing Li; Yang Ge; Jing Luo
Journal:  Echocardiography       Date:  2021-05-31       Impact factor: 1.874

3.  Adoption of routine telemedicine in Norwegian hospitals: progress over 5 years.

Authors:  Paolo Zanaboni; Richard Wootton
Journal:  BMC Health Serv Res       Date:  2016-09-20       Impact factor: 2.655

4.  Pediatric cardiothoracic program in Malaysia: a study based on the outcome of the program.

Authors:  Cornelius Piros Kulandasamy Pillai; Yoshitoku Yoshida; Patrick Justin Lawrence; Eiko Yamamoto; Joshua A Reyer; Nobuyuki Hamajima1
Journal:  Nagoya J Med Sci       Date:  2016-02       Impact factor: 1.131

5.  Echoes of Telecardiology Guideline.

Authors:  Silvio Henrique Barberato; Marcelo Antônio Cartaxo Queiroga Lopes
Journal:  Arq Bras Cardiol       Date:  2020-01       Impact factor: 2.000

Review 6.  A practical guide to graphic communication for quality assurance, education, and patient care in echocardiography.

Authors:  Gerald I Cohen
Journal:  Echocardiography       Date:  2019-09-21       Impact factor: 1.724

7.  Establishment of a cardiac telehealth program to support cardiovascular diagnosis and care in a remote, resource-poor setting in Uganda.

Authors:  Alyssa DeWyer; Amy Scheel; Jenipher Kamarembo; Rose Akech; Allan Asiimwe; Andrea Beaton; Bua Bobson; Lesley Canales; Kristen DeStigter; Dhruv S Kazi; Gene F Kwan; Chris T Longenecker; Peter Lwabi; Meghna Murali; Emma Ndagire; Judith Namuyonga; Rachel Sarnacki; Isaac Ssinabulya; Emmy Okello; Twalib Aliku; Craig Sable
Journal:  PLoS One       Date:  2021-08-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.